Results 1 to 10 of about 13,700 (205)

Bloqueo de inmunoglobulina E en el asma grave [PDF]

open access: yesRevista Alergia México, 2020
El asma es una enfermedad inflamatoria crónica y heterogénea que afecta las vías respiratorias inferiores tanto de niños como de adultos. Los pacientes en quienes se han abordado factores modificables y continúan con episodios graves de asma aún después ...
Jessica Purizaca-Bazán   +1 more
doaj   +2 more sources

Uso de medicamentos en pacientes pediátricos con COVID-19 hospitalizados en un hospital de referencia de Lima, Perú, 2020-2022 [PDF]

open access: yesRevista Peruana de Medicina Experimental y Salud Pública, 2023
El objetivo del estudio fue describir el uso de medicamentos en pacientes pediátricos con COVID-19 hospitalizados en el Instituto Nacional de Salud del Niño – San Borja (INSN-SB) de Lima, Perú, entre marzo del 2020 y marzo del 2022.
Medalit Luna-Vilchez   +4 more
doaj   +2 more sources

Sensibilización a ácaros e inmunoglobulina E total en niños alérgicos

open access: yesMedisur, 2013
La incidencia y prevalencia de las enfermedades alérgicas en la infancia han aumentado considerablemente en los países desarrollados en los últimos 20-30 años.
Nivia López Ramírez   +5 more
doaj   +3 more sources

Inmunoglobulina E en pacientes que acuden al Hospital Dr. Rafael Rodríguez Zambrano de Manta, Ecuador

open access: yesKasmera
La incidencia y prevalencia de las enfermedades alérgicas han aumentado en los últimos años, por lo que se han estudiado los alergenos, desde el punto de vista inmunológico, estructural y funcional.
Zuleyka García Santana   +1 more
doaj   +2 more sources

ACTUALIZACIÓN DEL CONSENSO CHILENO SOCHINEP-SER PARA EL MANEJO DE LAS SIBILANCIAS RECURRENTES DEL PREESCOLAR

open access: yesNeumología Pediátrica, 2023
Las sibilancias recurrentes del preescolar son un problema prevalente. 50% de todos los niños tiene al menos un episodio de sibilancias en los primeros 6 años. Sin embargo, solo 4 % de los menores de 4 años tiene diagnóstico de asma.
Ana María Herrera G.   +12 more
doaj   +1 more source

Sensitivity of a Hymenoptera serological immunoglobulin (Ig)E assay for the diagnosis of venom hypersensitivity in dogs

open access: yesVeterinary Dermatology, Volume 34, Issue 6, Page 543-553, December 2023., 2023
Background – Hymenoptera envenomation with honey bee (Apis mellifera) and paper wasp (Polistes spp.) may cause life‐threatening anaphylaxis in dogs. In human patients, clinical history, intradermal testing (IDT) and measurement of allergen‐specific serological immunoglobulin (Ig)E (sIgE) are used to support a diagnosis of Hymenoptera venom ...
Hilary H. Chan   +3 more
wiley   +1 more source

Immunoglobulin E‐specific allergens against leaf in serum of dogs with clinical features of grass leaf allergy

open access: yesVeterinary Dermatology, Volume 34, Issue 5, Page 393-403, October 2023., 2023
Background – Grass leaf has been suspected to cause immunoglobulin (Ig)E‐mediated immediate hypersensitivity reactions both in humans and in dogs. However, most studies in this area are case control studies without in vitro data showing the involvement of IgE in the reaction.
Ken Mason, Janet Davies, Merja Ruutu
wiley   +1 more source

Equine allergic skin diseases: Clinical consensus guidelines of the World Association for Veterinary Dermatology

open access: yesVeterinary Dermatology, Volume 34, Issue 3, Page 175-208, June 2023., 2023
Abstract Background Allergic skin diseases are common in horses worldwide. The most common causes are insect bites and environmental allergens. Objectives To review the current literature and provide consensus on pathogenesis, diagnosis, treatment and prevention. Materials and Methods The authors reviewed the literature up to November 2022.
R. Marsella   +6 more
wiley   +1 more source

Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases

open access: yesVeterinary Dermatology, Volume 33, Issue 4, Page 321-e75, August 2022., 2022
Background –Canine atopic dermatitis (cAD) is an allergic skin disease affecting approximately 10% of dogs. Allergen immunotherapy (AIT) is currently the only treatment option able to induce tolerance to the causative allergens. Objective – To retrospectively establish the efficacy of AIT in atopic dogs.
Evelien E. M. Fennis   +6 more
wiley   +1 more source

An international seroprevalence survey of the IgE sensitisation to the Dermatophagoides farinae house dust mite and two of its major allergens (Der f 2, Zen 1) in atopic dogs

open access: yesVeterinary Dermatology, Volume 33, Issue 2, Page 117-e34, April 2022., 2022
Background – Dogs with atopic dermatitis are often immunoglobulin (Ig)E‐sensitised to Dermatophagoides farinae (Df) house dust mites, yet limited data exist on the sensitisation rates to the individual Df allergens, Der f 2 and Zen 1. Objectives – To determine the IgE sensitisation rates to Df, Der f 2 and Zen 1 in atopic dogs from geographically ...
Claude Favrot   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy